Is it safe for lupus patients to take estrogen? It depends ....

Journal of Clinical Rheumatology

Volumn 13, Issue 1, 2007, Pages 1-2

  Abdou, Nabih I ^a   Rider, Virginia ^b  

^a ST LUKE S HOSPITAL   (United States)

^b PITTSBURG STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

9 METHOXYELLIPTICINE; ANDROGEN; ANTIESTROGEN; CALCINEURIN; CD40 LIGAND; CYTOTOXIC AGENT; DRUG METABOLITE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ORAL CONTRACEPTIVE AGENT; PLACEBO; SEX HORMONE; STEROID; UNCLASSIFIED DRUG;

ANTIPHOSPHOLIPID SYNDROME; CLINICAL TRIAL; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG CONTRAINDICATION; DRUG MEGADOSE; DRUG METABOLISM; DRUG SAFETY; DRUG WITHDRAWAL; EDITORIAL; GENETIC SUSCEPTIBILITY; HORMONE SUBSTITUTION; HUMAN; HYPERCOAGULABILITY; LUPUS ERYTHEMATOSUS; MENSTRUATION; NONHUMAN; ORAL CONTRACEPTION; PATIENT MONITORING; POSTMENOPAUSE; PRIORITY JOURNAL; RECEPTOR BLOCKING; SEX DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; THROMBOSIS; UPREGULATION;

AGE FACTORS; ESTROGENS; FEMALE; HEALTH STATUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SEX FACTORS;

EID: 33846804176     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rhu.0000256285.49307.7e     Document Type: Editorial

References (14)

1. Greenstein BD. Lupus: why women? J Women's Health Gender Med. 2001;10:233-239.
2. Rider V, Abdou NI. Sexual dimorphism and the immune system. In: Legato MJ, ed. Principles of Gender Specific Medicine. Boston, MA: Elsevier Academic Press; 2004:1071-1081.
3. Rider V, Abdou NI. Hormonal influences in the expression of systemic lupus erythematosus. In: Tsokos BC, Gordon C, Smolen JS, eds. Systemic Lupus Erythematosus: A Companion to Rheumatology. Edinburgh: Mosby (in press).
4. Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2550-2558.
5. Buyon JP, Petri MA, Kim MY, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med. 2005;142:953-962.
6. Theofilopoulos AN, Dixon FJ. Murine models of SLE. Adv Immunol. 1985;37:269-390.
7. Lahita RG, Bradlow L, Fishman J, et al. Estrogen metabolism in SLE. Patients and family members. Arthritis Rheum. 1982;25:843.
8. Rider V, Foster RT, Evans MJ, et al. Gender differences in autoimmunity: estrogen increases calcineurin A2 expression in systemic lupus erythematosus. Clin Immunol Immunopathol. 1998;89:171-180.
9. Rider V, Jones S, Evans M, et al. Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J Rheumatol. 2001;28:2644-2649.
10. Suenaga R, Mitamura K, Evans MJ, et al. Binding affinity and quantity of estrogen receptor in peripheral blood monocytes of patients with systemic lupus erythematosus. Lupus. 1996;5:227-231.
11. Rider V, Li X, Peterson G, et al. Differential expression of estrogen receptors in women with systemic lupus erythematosus. J Rheumatol. 2006;33:1093-1101.
12. Santos-Ocampo AS. New onset lupus eythematosus in a transgender man: possible role of feminizing sex hormones. J Clin Rheumatol. 2007;13:29-30.
13. Kawamoto M, Harigai M, Hara M, et al. Expression and function of inducible co-stimulation in patients with systemic lupus erythematosus: possible involvement in excessive interferon-γ and anti-double-stranded DNA antibody production. Arthritis Res Ther. 2006;8:62.
14. Greenstein BD, Dhaher YY, Bridges E, et al. Effects of an aromatase inhibitor on thymus and kidney and on oestrogen receptors in female MRL/MP-lpr/lpr mice. Lupus. 1993;2:221-224.